PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31

PETMED EXPRESS INC

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$1.15−0.03 (-2.54%)

Close on Oct 19, 2026

Market cap: $24.93M
P/E (TTM): –
Dividend yield: 0.00%

PETMED EXPRESS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31	FY 2014 2014-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31	FY 2011 2011-03-31	FY 2010 2010-03-31
Revenue	179	227	274	248	272	304	284	283	274	249	235	229	233	228	238	232	238
Cost of Revenue	–	158	189	171	195	219	203	188	176	170	158	153	156	151	158	148	146
Gross Profit	50	69	85	77	77	84	81	95	98	79	76	76	78	77	80	84	92
General & Administrative	51	39	55	42	31	30	25	25	24	23	21	21	21	22	22	22	22
Advertising Expenses	22	24	31	25	19	22	23	22	19	18	22	25	27	27	30	27	28
Operating Expenses	109	71	93	70	53	54	50	49	46	42	44	49	49	50	54	51	51
Operating Income	-59	-1.53	-8.16	6.05	24	31	31	46	52	37	32	28	28	27	26	33	41
Interest & Investment Income	–	–	–	2.07	0.34	0.31	1.75	1.86	0.66	0.14	0.19	0.18	0.19	0.31	0.29	0.38	0.20
Other Non-Operating Income	1.31	0.94	1.89	1.39	-0.11	0.42	2.92	2.95	1.65	0.44	0.18	0.19	0.18	0.30	0.35	0.25	0.20
Asset Impairment Charges	27	1.20	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	-57	-0.59	-6.27	7.45	24	31	34	49	54	38	33	28	28	27	26	33	41
Income Tax Expense	-0.07	5.68	1.19	2.31	5.47	7.03	8.04	11	17	14	12	10	10	10	9.71	12	15
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	–	–	–	17	21	26
Net Income	-57	-6.27	-7.46	5.14	19	24	26	38	37	24	21	17	18	17	17	21	26
EPS (Basic)(per share)	-2.74	-0.30	-0.37	0.25	0.93	1.19	1.29	1.84	1.83	1.18	1.02	0.87	0.90	0.86	0.81	0.93	1.15
EPS (Diluted)(per share)	-2.74	-0.30	-0.37	0.25	0.92	1.19	1.29	1.84	1.82	1.17	1.02	0.87	0.90	0.86	0.80	0.92	1.14
Shares Outstanding (Basic, Weighted)(shares)	21	21	20	20	20	20	20	20	20	20	20	20	0.02	20	21	23	23
Shares Outstanding (Diluted, Weighted)(shares)	21	21	20	20	20	20	20	20	20	20	20	20	0.02	20	21	23	23
Dividend per Share(per share)	0.00	0.00	0.60	1.20	1.20	1.12	1.08	1.06	0.85	0.76	0.72	0.68	0.66	1.60	0.53	0.48	0.30
EBITDA	-49	5.51	-1.11	9.60	27	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 27.9%
Operating margin: -18.2%
Net margin: -17.3%
Return on equity, FY2026: -100.4%

Financial strength

Current ratio: 0.68
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 32.2%

Valuation

P/E ratio: –
Price to sales: 0.15
Price to book: 1.08
Dividend yield: 0.00%